Vade vs. Paubox
A side-by-side comparison based on G2 review data.
| Metric | Vade | Paubox |
|---|---|---|
| Overall rating | 4.6 | 4.9 |
| Review count | 180 | 664 |
| Ease of use | 9.5 | 9.7 |
| Ease of setup | 9.4 | 9.2 |
| Quality of support | 9.4 | 9.8 |
| Meets requirements | 9.3 | 9.8 |
| NPS | 75.147929 | 92.727273 |
| Small Business | 55.9% | 85.4% |
| Mid-Market | 38.5% | 13.0% |
| Enterprise | 5.6% | 1.7% |
| Total page views | 173 | 5,334 |
| Total LLM citations | 834 | 7,289 |
Vade
Vade is a global cybersecurity company specializing in developing threat detection and response technology with artificial intelligence. Founded in 2009 in Hem, France, Vade has eight global locations, including offices in the US, France, Japan, Canada, and Israel. Vade for M365 is a threat detection and response solution for Microsoft 365 that is purpose-built for MSPs.
- Real-time Protection
- Artificial Intelligence
- Comprehensive Analysis
- Malware Protection
- AI Technology
- Phishing Protection
Paubox
Paubox is a HIPAA compliant email security platform designed for healthcare organizations. It provides outbound email encryption and AI-powered inbound email protection, helping organizations safeguard protected health information (PHI) without changing how staff or patients use email. Email remains a critical communication tool in healthcare, but standard platforms like Google Workspace and Microsoft 365 are not HIPAA compliant on their own.
- Ease of Use
- Security
- Customer Support
- Email Security
- Setup Ease
- Secure Communication